Patients undergoing treatment for prostate cancer using proton beam therapy reported a higher quality of life in early follow-up but similar QoL scores at 2 years compared to 3-D conformal and intensity-modulated radiation therapy, according to a new study.
Hormone therapy plus current treatments improves survival in prostate cancer
March 23rd 2023Darolutamide increased overall survival compared to placebo in the overall patient population and patients with high-volume, high-risk mHSPC as well as in patients with low-risk metastatic hormone-sensitive prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512